A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen Therapy to Sham Therapy in the Treatment of Diabetic Foot Ulcers

por Niederauer, Mark Q., Michalek, Joel E., Armstrong, David G.
Publicado 2017

Comparison of the Use of a Physiologically Based Pharmacokinetic Model and a Classical Pharmacokinetic Model for Dioxin Exposure Assessments

por Emond, Claude, Michalek, Joel E., Birnbaum, Linda S., DeVito, Michael J.
Publicado 2005

Coding Variation and Adherence to Methodological Standards in Cardiac Research Using the National Inpatient Sample

por Ostrominski, John W., Amione-Guerra, Javier, Hernandez, Brian, Michalek, Joel E., Prasad, Anand
Publicado 2021

Serum Dioxin, Testosterone, and Subsequent Risk of Benign Prostatic Hyperplasia: A Prospective Cohort Study of Air Force Veterans

por Gupta, Amit, Ketchum, Norma, Roehrborn, Claus G., Schecter, Arnold, Aragaki, Corinne C., Michalek, Joel E.
Publicado 2006

Plexin-B2 and Semaphorins Do Not Drive Rhabdomyosarcoma Proliferation or Migration

por Karki, Anju, Purohit, Reshma, Tosoni, Sofia, Bharathy, Narendra, Michalek, Joel E, Chen, Sonja, Keller, Charles
Publicado 2022

Receptor-driven invasion profiles in diffuse intrinsic pontine glioma

por Karki, Anju, Berlow, Noah E, Kim, Jin-Ah, Hulleman, Esther, Liu, Qianqian, Michalek, Joel E, Keller, Charles
Publicado 2021

PEGylated talazoparib enhances therapeutic window of its combination with temozolomide in Ewing sarcoma

por Del Pozo, Vanessa, Robles, Andrew J., Fontaine, Shaun D., Liu, Qianqian, Michalek, Joel E., Houghton, Peter J., Kurmasheva, Raushan T.
Publicado 2021

The impact of tackle football injuries on the American healthcare system with a neurological focus

por McGinity, Michael J., Grandhi, Ramesh, Michalek, Joel E., Rodriguez, Jesse S., Trevino, Aron M., McGinity, Ashley C., Seifi, Ali
Publicado 2018

Correction: The impact of tackle football injuries on the American healthcare system with a neurological focus

por McGinity, Michael J., Grandhi, Ramesh, Michalek, Joel E., Rodriguez, Jesse S., Trevino, Aron M., McGinity, Ashley C., Seifi, Ali
Publicado 2018

Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model

por Abraham, Jinu, Nelon, Laura D., Kubicek, Courtney B., Kilcoyne, Aoife, Hampton, Sheila T., Zarzabal, Lee Ann, Giles, Francis J., Michalek, Joel E., Rubin, Brian P., Keller, Charles
Publicado 2011

Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study

por Michalek, Joel E, Preuss, Harry G, Croft, Harry A, Keith, Patti L, Keith, Samuel C, Dapilmoto, Monika, Perricone, Nicholas V, Leckie, Robert B, Kaats, Gilbert R
Publicado 2011

Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma

por Kikuchi, Ken, Hettmer, Simone, Aslam, M. Imran, Michalek, Joel E., Laub, Wolfram, Wilky, Breelyn A., Loeb, David M., Rubin, Brian P., Wagers, Amy J., Keller, Charles
Publicado 2014

Age-associated genes in human mammary gland drive human breast cancer progression

por Gu, Xiang, Wang, Bingzhi, Zhu, Haiyan, Zhou, You, Horning, Aaron M., Huang, Tim H-M, Chen, Yidong, Houghton, Peter, Lai, Zhao, Michalek, Joel E., Sun, Lu-Zhe
Publicado 2020

Bone marrow-derived cell regulation of skeletal muscle regeneration

por Sun, Dongxu, Martinez, Carlo O., Ochoa, Oscar, Ruiz-Willhite, Lourdes, Bonilla, Jose R., Centonze, Victoria E., Waite, Lindsay L., Michalek, Joel E., McManus, Linda M., Shireman, Paula K.
Publicado 2009

Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma

por Berlow, Noah E., Grasso, Catherine S., Quist, Michael J., Cheng, Mingshan, Gandour-Edwards, Regina, Hernandez, Brian S., Michalek, Joel E., Ryan, Christopher, Spellman, Paul, Pal, Ranadip, Million, Lynn S., Renneker, Mark, Keller, Charles
Publicado 2020

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma

por Kim, Jin-Ah, Crawford, Kenneth A., Spada, Piero A., Martin, Leah R., Zhang, Jiaqi, Wong, Rain, Reid, Joel M., Stewart, Clinton F., Frank, Timothy M., Liu, Qianqian, Michalek, Joel E., Keller, Charles
Publicado 2023

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and (18)F-FMISO PET

por Huang, Shiliang, Michalek, Joel E., Reardon, David A., Wen, Patrick Y., Floyd, John R., Fox, Peter T., Clarke, Geoffrey D., Jerabek, Paul A., Schmainda, Kathleen M., Muzi, Mark, Hyun, Hyewon, Lee, Eudocia Quant, Brenner, Andrew J.
Publicado 2021

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma

por Randolph, Matthew E., Cleary, Megan M., Bajwa, Zia, Svalina, Matthew N., Young, Michael C., Mansoor, Atiya, Kaur, Pali, Bult, Carol J., Goros, Martin W., Michalek, Joel E., Xiang, Sunny, Keck, James, Krasnoperov, Valery, Gill, Parkash, Keller, Charles
Publicado 2017

Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma

por Kikuchi, Ken, Taniguchi, Eri, Chen, Hung-I Harry, Svalina, Matthew N, Abraham, Jinu, Huang, Elaine T, Nishijo, Koichi, Davis, Sean, Louden, Christopher, Zarzabal, Lee Ann, Recht, Olivia, Bajwa, Ayeza, Berlow, Noah, Suelves, Mònica, Perkins, Sherrie L, Meltzer, Paul S, Mansoor, Atiya, Michalek, Joel E, Chen, Yidong, Rubin, Brian P, Keller, Charles
Publicado 2013

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma

por Svalina, Matthew N., Kikuchi, Ken, Abraham, Jinu, Lal, Sangeet, Davare, Monika A., Settelmeyer, Teagan P., Young, Michael C., Peckham, Jennifer L., Cho, Yoon-Jae, Michalek, Joel E., Hernandez, Brian S., Berlow, Noah E., Jackson, Melanie, Guillaume, Daniel J., Selden, Nathan R., Bigner, Darell D., Nazemi, Kellie J., Green, Sarah C., Corless, Christopher L., Gultekin, Sakir, Mansoor, Atiya, Rubin, Brian P., Woltjer, Randall, Keller, Charles
Publicado 2016